scholarly journals Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial

2019 ◽  
Vol 20 (2) ◽  
pp. 297-310 ◽  
Author(s):  
David Cella ◽  
Viktor Grünwald ◽  
Bernard Escudier ◽  
Hans J Hammers ◽  
Saby George ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Patient Reported Outcomes ◽  
Advanced Renal Cell Carcinoma ◽  
Phase 3 ◽  
Patient Reported

TIVO-3: A Phase 3, Randomised, Open-Label Study Comparing Tivozanib to Sorafenib in Patients with Advanced Renal Cell Carcinoma

2019 ◽  
Author(s):  
Brian Rini ◽  
Sumanta K. Pal ◽  
Bernard J. Escudier ◽  
Michael B. Atkins ◽  
Thomas E. Hutson ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Study ◽  
Label Study

scholarly journals Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma

Kidney Cancer ◽  
2020 ◽  
Vol 4 (1) ◽  
pp. 29-39
Author(s):  
Nizar M. Tannir ◽  
Thomas Powles ◽  
Bernard Escudier ◽  
Frede Donskov ◽  
Viktor Grünwald ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document